Latham & Watkins LLP

Jennifer Bragg is a nationally recognized lawyer advising US Food and Drug Administration (FDA) regulated companies facing complex legal and regulatory challenges, government investigations, and related litigation.

Jennifer draws on more than two decades of experience, including as Associate Chief Counsel for Enforcement in the FDA’s Office of Chief Counsel, to advise companies and boards of directors on:

• • US Department of Justice (DOJ) and state attorney general investigations
  • FDA and US Drug Enforcement Administration (DEA) enforcement actions
  • Internal investigations
  • Complex commercial and regulatory issues, often in the context of broader litigation and strategic transactions

She develops commercially focused strategies for clients to resolve regulatory issues, minimize litigation and enforcement risks, and overcome transactional hurdles. She counsels boards and compliance departments on corporate compliance program development and other protective measures designed to mitigate the risk of litigation.

While at the FDA, Jennifer advised its Office of Criminal Investigations, where she tried to verdict four criminal jury cases involving violations of the Federal Food, Drug, and Cosmetic Act (FDCA) and other federal statutes. She was designated by the DOJ to serve as a special assistant US attorney in ongoing criminal investigations under the FDCA and served as the FDA Office of Chief Counsel’s primary liaison with the Office of Criminal Investigations relating to policy issues.

A recognized thought leader, she frequently speaks at leading industry conferences, including for the Food and Drug Law Institute, Medical Device Manufacturers Association, AdvaMed, International Association of Defense Counsel, and DRI.